Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • Molecular Systems Biology (Home)
    • The EMBO Journal
    • EMBO reports
    • EMBO Molecular Medicine
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Current Issue
  • Archive
  • Subject Collections
  • Review Series & Focuses
  • Podcasts & Videos

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Bibliometrics
  • Open Access
  • Referee Guidelines

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Customer Service
  • Home
  • Subject Collection(s)

Methods & Resources

  • Open Access
    A unified approach for quantifying and interpreting DNA shape readout by transcription factors
    A unified approach for quantifying and interpreting DNA shape readout by transcription factors
    1. H Tomas Rube1,
    2. Chaitanya Rastogi1,2,
    3. Judith F Kribelbauer1,3 and
    4. Harmen J Bussemaker (hjb2004{at}columbia.edu)*,1,3
    1. 1Department of Biological Sciences, Columbia University, New York, NY, USA
    2. 2Program in Applied Physics and Applied Mathematics, Columbia University, New York, NY, USA
    3. 3Department of Systems Biology, Columbia University Medical Center, New York, NY, USA
    1. ↵*Corresponding author. Tel: +1 212 854 9932; E‐mail: hjb2004{at}columbia.edu

    The sequence dependence of DNA shape parameters is analyzed to clarify the relationship between transcription factor binding specificity, DNA shape readout and scoring matrices. Statistical methods for identifying DNA shape readout are developed.

    Synopsis

    The sequence dependence of DNA shape parameters is analyzed to clarify the relationship between transcription factor binding specificity, DNA shape readout and scoring matrices. Statistical methods for identifying DNA shape readout are developed.

    • A unified mathematical representation of the DNA sequence dependence of shape and transcription factor (TF) binding is proposed for analyzing shape readout.

    • Linear models based on mononucleotide features alone account for 60–70% of the variation of DNA shape.

    • Most of the residual variance can be explained by adding dinucleotide features as sequence‐to‐shape predictors to the model.

    • A post hoc analysis method is presented for interpreting any mechanism‐agnostic protein‐DNA binding model in terms of shape readout.

    • DNA binding specificity
    • DNA shape
    • sequence‐readout mechanisms
    • statistical analysis
    • transcription factors

    Mol Syst Biol. (2017) 14: e7902

    • Received July 28, 2017.
    • Revision received January 26, 2018.
    • Accepted January 31, 2018.
    • © 2018 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    H Tomas Rube, Chaitanya Rastogi, Judith F Kribelbauer, Harmen J Bussemaker
    Published online 22.02.2018
    • Chromatin, Epigenetics, Genomics & Functional Genomics
    • Methods & Resources
    • Transcription
  • Open Access
    Large‐scale image‐based profiling of single‐cell phenotypes in arrayed CRISPR‐Cas9 gene perturbation screens
    Large‐scale image‐based profiling of single‐cell phenotypes in arrayed CRISPR‐Cas9 gene perturbation screens
    1. Reinoud de Groot1,
    2. Joel Lüthi1,2,
    3. Helen Lindsay1,
    4. René Holtackers1 and
    5. Lucas Pelkmans (lucas.pelkmans{at}imls.uzh.ch)*,1
    1. 1Institute of Molecular Life Sciences, University of Zürich, Zürich, Switzerland
    2. 2Systems Biology PhD program, Life Science Zürich Graduate School ETH Zürich and University of Zürich, Zürich, Switzerland
    1. ↵*Corresponding author. Tel: +41 44 63 53 123; E‐mail: lucas.pelkmans{at}imls.uzh.ch

    The CRISPR‐Cas9 system is applied in high‐content image‐based gene perturbation screens. Computational classifiers trained between wild‐type cells and cells expressing Cas9 and gRNA enable the profiling of multivariate single cell phenotypes.

    Synopsis

    The CRISPR‐Cas9 system is applied in high‐content image‐based gene perturbation screens. Computational classifiers trained between wild‐type cells and cells expressing Cas9 and gRNA enable the profiling of multivariate single cell phenotypes.

    • CRISPR‐Cas9 mediated gene perturbation by transient transfection of a single targeting plasmid is combined with large‐scale, image‐based profiling.

    • Methods are developed for the construction of arrayed CRISPR‐Cas9 screening libraries.

    • Single cell phenotypes are profiled by training computational classifiers between transfected and non‐transfected cells from the same well.

    • Profiling of a marker of the nuclear pore complex identifies several classes of phenotypic perturbations.

    • arrayed library
    • CRISPR‐Cas9
    • functional genomics
    • nuclear pore complex
    • single‐cell phenotypic profiling

    Mol Syst Biol. (2018) 14: e8064

    • Received October 23, 2017.
    • Revision received December 18, 2017.
    • Accepted December 21, 2017.
    • © 2018 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Reinoud de Groot, Joel Lüthi, Helen Lindsay, René Holtackers, Lucas Pelkmans
    Published online 23.01.2018
    • Chromatin, Epigenetics, Genomics & Functional Genomics
    • Genome-Scale & Integrative Biology
    • Methods & Resources
  • Open Access
    Assigning function to natural allelic variation via dynamic modeling of gene network induction
    Assigning function to natural allelic variation via dynamic modeling of gene network induction
    1. Magali Richard (magali.richard{at}univ-grenoble-alpes.fr)*,1,2,
    2. Florent Chuffart1,
    3. Hélène Duplus‐Bottin1,
    4. Fanny Pouyet1,
    5. Martin Spichty1,
    6. Etienne Fulcrand1,
    7. Marianne Entrevan1,
    8. Audrey Barthelaix1,
    9. Michael Springer3,
    10. Daniel Jost (daniel.jost{at}univ-grenoble-alpes.fr)*,2 and
    11. Gaël Yvert (gael.yvert{at}ens-lyon.fr)*,1
    1. 1Laboratoire de Biologie et de Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, CNRS, Université Lyon 1 Université de Lyon, Lyon, France
    2. 2Univ. Grenoble Alpes, CNRS CHU Grenoble Alpes Grenoble INP TIMC‐IMAG, Grenoble, France
    3. 3Department of Systems Biology, Harvard Medical School, Boston, MA, USA
    1. ↵* Corresponding author. Tel: +33 4 56 52 00 68; E‐mail: magali.richard{at}univ-grenoble-alpes.fr
      Corresponding author. Tel: +33 4 56 52 00 69; E‐mail: daniel.jost{at}univ-grenoble-alpes.fr
      Corresponding author. Tel: +33 4 72 72 80 00; E‐mail: gael.yvert{at}ens-lyon.fr

    An approach based on genotype‐specific gene regulatory network models is used to examine the functional consequences of yeast GAL3 sequence variants. This framework can be more generally applied to the mechanistic interpretation of genetic variants.

    Synopsis

    An approach based on genotype‐specific gene regulatory network models is used to examine the functional consequences of yeast GAL3 sequence variants. This framework can be more generally applied to the mechanistic interpretation of genetic variants.

    • The principle of the proposed approach is linking genetic variation to informative changes of parameter values of a regulatory network model.

    • Experimental analyses of the yeast GAL network shows that GAL3 natural variation is sufficient to convert a gradual response into a binary switch.

    • Dynamic network modeling successfully maps alleles to specific locations of the parameter space, allowing functional inference of DNA polymorphisms.

    • galactose
    • personalized medicine
    • SNP function
    • stochastic model
    • yeast

    Mol Syst Biol. (2018) 14: e7803

    • Received June 7, 2017.
    • Revision received December 15, 2017.
    • Accepted December 18, 2017.
    • © 2018 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Magali Richard, Florent Chuffart, Hélène Duplus‐Bottin, Fanny Pouyet, Martin Spichty, Etienne Fulcrand, Marianne Entrevan, Audrey Barthelaix, Michael Springer, Daniel Jost, Gaël Yvert
    Published online 15.01.2018
    • Methods & Resources
    • Network Biology
    • Quantitative Biology & Dynamical Systems
  • Open Access
    Methods to drive systems biology forward
    Methods to drive systems biology forward
    1. Maria Polychronidou (maria.polychronidou{at}embo.org)1 and
    2. Thomas Lemberger (thomas.lemberger{at}embo.org)1
    1. 1EMBO, Heidelberg, Germany

    The development of new methodologies has driven the expansion of systems biology over the past decades. Technological breakthroughs in sequencing, in quantitative proteomics, in single‐cell measurements, to name only a few, have each opened up whole new fields of research. To highlight the importance of new experimental and computational methodologies in enabling novel biological discoveries, we are pleased to announce the introduction of a new Methods section in Molecular Systems Biology (http://msb.embopress.org/authorguide#methodsguide).

    We are excited to announce our new Methods section, a “new home” for papers focused on new methodological advances in systems and synthetic biology. We look forward to publishing method papers that put forward new concepts and innovative approaches addressing important biological questions.

    Mol Syst Biol. (2017) 13: 996

    • © 2017 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Maria Polychronidou, Thomas Lemberger
    Published online 21.12.2017
    • Methods & Resources
  • Open Access
    A framework for exhaustively mapping functional missense variants
    A framework for exhaustively mapping functional missense variants
    1. Jochen Weile1,2,3,4,†,
    2. Song Sun1,2,3,4,5,†,
    3. Atina G Cote1,2,3,
    4. Jennifer Knapp1,2,3,
    5. Marta Verby1,2,3,
    6. Joseph C Mellor2,6,
    7. Yingzhou Wu1,2,3,4,
    8. Carles Pons7,
    9. Cassandra Wong1,2,
    10. Natascha van Lieshout1,
    11. Fan Yang1,2,3,4,
    12. Murat Tasan1,2,3,4,
    13. Guihong Tan2,3,
    14. Shan Yang8,
    15. Douglas M Fowler9,
    16. Robert Nussbaum8,
    17. Jesse D Bloom10,
    18. Marc Vidal11,12,
    19. David E Hill11,
    20. Patrick Aloy7,13 and
    21. Frederick P Roth (fritz.roth{at}utoronto.ca)*,1,2,3,4,14
    1. 1Lunenfeld‐Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada
    2. 2The Donnelly Centre, University of Toronto, Toronto, ON, Canada
    3. 3Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
    4. 4Department of Computer Science, University of Toronto, Toronto, ON, Canada
    5. 5Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
    6. 6SeqWell Inc, Boston, MA, USA
    7. 7Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute for Science and Technology, Barcelona, Catalonia, Spain
    8. 8Invitae Corp., San Francisco, CA, USA
    9. 9Department of Genome Sciences, University of Washington, Seattle, WA, USA
    10. 10Fred Hutchinson Research Center, Seattle, WA, USA
    11. 11Center for Cancer Systems Biology (CCSB), Dana‐Farber Cancer Institute, Boston, MA, USA
    12. 12Department of Genetics, Harvard Medical School, Boston, MA, USA
    13. 13Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Catalonia, Spain
    14. 14Canadian Institute for Advanced Research, Toronto, ON, Canada
    1. ↵*Corresponding author. Tel: +1 416 946 5130; E‐mail: fritz.roth{at}utoronto.ca
    1. ↵† These authors contributed equally to this work

    A new framework combining random codon‐mutagenesis and multiplexed functional variation assays with computational imputation, allows the comprehensive identification of functional missense variation. The approach is applied to identify pathogenic variation in six human genes.

    Synopsis

    A new framework combining random codon‐mutagenesis and multiplexed functional variation assays with computational imputation, allows the comprehensive identification of functional missense variation. The approach is applied to identify pathogenic variation in six human genes.

    • A modular deep mutational scanning (DMS) framework combines random codon‐mutagenesis and multiplexed functional variation assays with computational imputation and refinement.

    • The framework is applied to four human proteins corresponding to six human genes and generates comprehensive functional variation maps covering > 13,000 missense variants.

    • These maps confidently identify pathogenic variation.

    • DMS is a promising approach for generating exhaustive maps of functional variation covering all human genes.

    • complementation
    • deep mutational scanning
    • genotype–phenotype
    • variants of uncertain significance

    Mol Syst Biol. (2017) 13: 957

    • Received August 9, 2017.
    • Revision received November 15, 2017.
    • Accepted November 18, 2017.
    • © 2017 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Jochen Weile, Song Sun, Atina G Cote, Jennifer Knapp, Marta Verby, Joseph C Mellor, Yingzhou Wu, Carles Pons, Cassandra Wong, Natascha van Lieshout, Fan Yang, Murat Tasan, Guihong Tan, Shan Yang, Douglas M Fowler, Robert Nussbaum, Jesse D Bloom, Marc Vidal, David E Hill, Patrick Aloy, Frederick P Roth
    Published online 21.12.2017
    • Chromatin, Epigenetics, Genomics & Functional Genomics
    • Genome-Scale & Integrative Biology
    • Methods & Resources
  • Open Access
    Natural language processing: put your model where your mouth is
    Natural language processing: put your model where your mouth is
    1. Rachel A Haggerty1 and
    2. Jeremy E Purvis (jeremy_purvis{at}med.unc.edu)1
    1. 1Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Molecular mechanisms are often described using “word models”—phrases intended to capture the interactions in a biological process. In their recent work, Sorger and colleagues (Gyori et al, 2017) provide a framework for converting word models into computational structures that can be simulated and compared to experimental data. By codifying word‐based descriptions of molecular phenomena, scientific communities can better evaluate, compare, and share mechanistic insights.

    See also: BM Gyori et al (November 2017)

    Molecular mechanisms are often described using “word models”, phrases intended to capture the interactions in a biological process. In their recent work, Sorger and colleagues (Gyori et al, 2017) provide a framework for converting word models into executable models.

    Mol Syst Biol. (2017) 13: 958

    • © 2017 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Rachel A Haggerty, Jeremy E Purvis
    Published online 18.12.2017
    • Computational Biology
    • Methods & Resources
    • Signal Transduction
  • Open Access
    Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
    Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
    1. Julia Jabs1,2,3,
    2. Franziska M Zickgraf4,5,
    3. Jeongbin Park1,3,
    4. Steve Wagner4,5,
    5. Xiaoqi Jiang6,
    6. Katharina Jechow1,2,
    7. Kortine Kleinheinz1,2,3,
    8. Umut H Toprak1,
    9. Marc A Schneider7,
    10. Michael Meister7,
    11. Saskia Spaich8,
    12. Marc Sütterlin8,
    13. Matthias Schlesner1,
    14. Andreas Trumpp4,5,9,
    15. Martin Sprick4,5,9,
    16. Roland Eils (r.eils{at}dkfz.de)*,1,2,3,10 and
    17. Christian Conrad (c.conrad{at}dkfz.de)*,1,2
    1. 1Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    2. 2Center for Quantitative Analysis of Molecular and Cellular Biosystems (BioQuant), University of Heidelberg, Heidelberg, Germany
    3. 3Department for Bioinformatics and Functional Genomics, Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University, Heidelberg, Germany
    4. 4Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI‐STEM) gGmbH, Heidelberg, Germany
    5. 5Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany
    6. 6Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
    7. 7Thoraxklinik at Heidelberg University Hospital, Member of the German Center for Lung Research (DZL), Heidelberg, Germany
    8. 8Department of Gynaecology and Obstetrics, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany
    9. 9German Cancer Consortium, Heidelberg, Germany
    10. 10Heidelberg Center for Personalized Oncology, DKFZ‐HIPO, DKFZ, Heidelberg, Germany
    1. ↵* Corresponding author. Tel: +49 6221 42 3600; E‐mail: r.eils{at}dkfz.de
      Corresponding author. Tel: +49 6221 54 51304; E‐mail: c.conrad{at}dkfz.de

    DeathPro, an automated microscopy‐based assay resolves cell death and proliferation inhibition in 2D and 3D cultures. Drug screens using DeathPro provide insights into the impact of culture systems on drug effects and their links to genomic features.

    Synopsis

    DeathPro, an automated microscopy‐based assay resolves cell death and proliferation inhibition in 2D and 3D cultures. Drug screens using DeathPro provide insights into the impact of culture systems on drug effects and their links to genomic features.

    • DeathPro resolves cytotoxic and cytostatic effects in drug screens with patient‐derived ovarian and lung cancer cells, organoids and co‐cultures with fibroblasts.

    • Drug responses in cancer organoids are more diverse than in 2D cultured cells.

    • Cytostatic drugs depend on culture systems, cytotoxic effects are independent of the culture format.

    • Genomic analysis of cancer patients links DNA repair deficiency to drug sensitivity in organoids.

    • cancer organoids
    • confocal microscopy
    • high‐throughput screening
    • personalized drug screen
    • pharmacogenomics

    Mol Syst Biol. (2017) 13: 955

    • Received April 18, 2017.
    • Revision received October 26, 2017.
    • Accepted October 27, 2017.
    • © 2017 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Julia Jabs, Franziska M Zickgraf, Jeongbin Park, Steve Wagner, Xiaoqi Jiang, Katharina Jechow, Kortine Kleinheinz, Umut H Toprak, Marc A Schneider, Michael Meister, Saskia Spaich, Marc Sütterlin, Matthias Schlesner, Andreas Trumpp, Martin Sprick, Roland Eils, Christian Conrad
    Published online 27.11.2017
    • Cancer
    • Methods & Resources
    • Pharmacology & Drug Discovery
  • Open Access
    From word models to executable models of signaling networks using automated assembly
    From word models to executable models of signaling networks using automated assembly
    1. Benjamin M Gyori1,†,
    2. John A Bachman1,†,
    3. Kartik Subramanian1,
    4. Jeremy L Muhlich1,
    5. Lucian Galescu2 and
    6. Peter K Sorger (peter_sorger{at}hms.harvard.edu)*,1
    1. 1Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA
    2. 2Institute for Human and Machine Cognition, Pensacola, FL, USA
    1. ↵*Corresponding author. Tel: +1 617 432 6901/6902; E‐mail: peter_sorger{at}hms.harvard.edu
    1. ↵† These authors contributed equally to this work

    “Integrated Network and Dynamical Reasoning Assembler” (INDRA) uses natural language processing systems to read descriptions of molecular mechanisms and assembles them into executable models.

    Synopsis

    “Integrated Network and Dynamical Reasoning Assembler” (INDRA) uses natural language processing systems to read descriptions of molecular mechanisms and assembles them into executable models.

    • INDRA decouples the curation of knowledge as word models from model implementation.

    • INDRA is connected to multiple natural language processing systems and can draw on information from curated databases.

    • INDRA can assemble dynamical models in rule‐based and reaction network formalisms, as well as Boolean networks and visualization formats.

    • INDRA is used to build models of p53 dynamics, resistance to targeted inhibitors of BRAF in melanoma, and the Ras signaling pathway from natural language.

    • computational modeling
    • natural language processing
    • signaling pathways

    Mol Syst Biol. (2017) 13: 954

    • Received March 23, 2017.
    • Revision received October 27, 2017.
    • Accepted October 27, 2017.
    • © 2017 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Benjamin M Gyori, John A Bachman, Kartik Subramanian, Jeremy L Muhlich, Lucian Galescu, Peter K Sorger
    Published online 24.11.2017
    • Computational Biology
    • Methods & Resources
    • Signal Transduction
  • Open Access
    Lysine acetylome profiling uncovers novel histone deacetylase substrate proteins in Arabidopsis
    Lysine acetylome profiling uncovers novel histone deacetylase substrate proteins in <em>Arabidopsis</em>
    1. Markus Hartl1,2,3,†,
    2. Magdalena Füßl1,2,4,†,
    3. Paul J Boersema5,9,
    4. Jan‐Oliver Jost6,10,
    5. Katharina Kramer1,
    6. Ahmet Bakirbas1,4,11,
    7. Julia Sindlinger6,
    8. Magdalena Plöchinger2,
    9. Dario Leister2,
    10. Glen Uhrig7,
    11. Greg BG Moorhead7,
    12. Jürgen Cox5,
    13. Michael E Salvucci8,
    14. Dirk Schwarzer6,
    15. Matthias Mann5 and
    16. Iris Finkemeier (iris.finkemeier{at}uni-muenster.de)*,1,2,4
    1. 1Plant Proteomics, Max Planck Institute for Plant Breeding Research, Cologne, Germany
    2. 2Plant Molecular Biology, Department Biology I, Ludwig‐Maximilians‐University Munich, Martinsried, Germany
    3. 3Mass Spectrometry Facility, Max F. Perutz Laboratories (MFPL), Vienna Biocenter (VBC), University of Vienna, Vienna, Austria
    4. 4Plant Physiology, Institute of Plant Biology and Biotechnology, University of Muenster, Muenster, Germany
    5. 5Proteomics and Signal Transduction, Max‐Planck Institute of Biochemistry, Martinsried, Germany
    6. 6Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany
    7. 7Department of Biological Sciences, University of Calgary, Calgary, AB, Canada
    8. 8US Department of Agriculture, Agricultural Research Service, Arid‐Land Agricultural Research Center, Maricopa, AZ, USA
    9. 9Present Address: Department of Biology, Institute of Biochemistry, ETH Zurich, Zurich, Switzerland
    10. 10Present Address: Leibniz‐Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany
    11. 11Present Address: Plant Biology Graduate Program University of Massachusetts Amherst, Amherst, USA
    1. ↵*Corresponding author. Tel: +49 251 8323805; E‐mail: iris.finkemeier{at}uni-muenster.de
    1. ↵† These authors contributed equally to this work

    A comprehensive lysine acetylome profiling identifies new potential substrate proteins of the Arabidopsis RPD3/HDA1‐KDACs with various subcellular localizations. HDA14 is identified as the first RPD3/HDA1‐KDAC, which is active in organelles.

    Synopsis

    A comprehensive lysine acetylome profiling identifies new potential substrate proteins of the Arabidopsis RPD3/HDA1‐KDACs with various subcellular localizations. HDA14 is identified as the first RPD3/HDA1‐KDAC, which is active in organelles.

    • 2,152 lysine acetylation sites are identified on 1,022 Arabidopsis protein groups.

    • Analyses with deacetylase inhibitors identify potential target sites of RPD3/HDA1 class‐KDACs of Arabidopsis.

    • HDA14 is found to be active in Arabidopsis chloroplasts and RuBisCo activase (RCA) Kac‐438 is identified as one of the potential HDA14 substrates.

    • Lysine acetylation on RCA‐K438 decreases the enzyme's ADP‐sensitivity, which is important for RCA inhibition under low‐light conditions.

    • Arabidopsis
    • histone deacetylases
    • lysine acetylation
    • photosynthesis
    • RuBisCO activase

    Mol Syst Biol. (2017) 13: 949

    • Received June 16, 2017.
    • Revision received September 22, 2017.
    • Accepted September 25, 2017.
    • © 2017 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Markus Hartl, Magdalena Füßl, Paul J Boersema, Jan‐Oliver Jost, Katharina Kramer, Ahmet Bakirbas, Julia Sindlinger, Magdalena Plöchinger, Dario Leister, Glen Uhrig, Greg BG Moorhead, Jürgen Cox, Michael E Salvucci, Dirk Schwarzer, Matthias Mann, Iris Finkemeier
    Published online 23.10.2017
    • Methods & Resources
    • Plant Biology
    • Post-translational Modifications, Proteolysis & Proteomics
  • Open Access
    In situ genotyping of a pooled strain library after characterizing complex phenotypes
    <em>In situ</em> genotyping of a pooled strain library after characterizing complex phenotypes
    1. Michael J Lawson1,†,
    2. Daniel Camsund1,†,
    3. Jimmy Larsson1,
    4. Özden Baltekin1,
    5. David Fange1 and
    6. Johan Elf (johan.elf{at}icm.uu.se)*,1
    1. 1Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
    1. ↵*Corresponding author. Tel: +46 18 4714678; E‐mail: johan.elf{at}icm.uu.se
    1. ↵† These authors contributed equally to this work

    The DuMPLING approach extends the use of advanced live‐cell microscopy to libraries of pool generated genetically diverse strains. The method is illustrated by tracking strains over six generations and precisely quantifying gene expression at the single molecule level.

    Synopsis

    The DuMPLING approach extends the use of advanced live‐cell microscopy to libraries of pool generated genetically diverse strains. The method is illustrated by tracking strains over six generations and precisely quantifying gene expression at the single molecule level.

    • A library of plasmids is pool synthesized, expressing a specific RNA barcode and an associated CRISPR interference guide RNA against different chromosomal genes.

    • Library phenotyping is demonstrated using time‐lapse single‐molecule fluorescence microscopy of bacteria growing for many generations in a microfluidic device.

    • The strains are genotyped in situ by six rounds of sequential fluorescent in situ hybridization probing in two colors.

    • DuMPLING
    • live cell
    • microfluidic
    • single cell
    • strain libraries

    Mol Syst Biol. (2017) 13: 947

    • Received August 23, 2017.
    • Revision received September 11, 2017.
    • Accepted September 22, 2017.
    • © 2017 The Authors. Published under the terms of the CC BY 4.0 license

    This is an open access article under the terms of the Creative Commons Attribution 4.0 License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

    Michael J Lawson, Daniel Camsund, Jimmy Larsson, Özden Baltekin, David Fange, Johan Elf
    Published online 17.10.2017
    • Methods & Resources
    • Quantitative Biology & Dynamical Systems

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5

Subject Areas

  • Ageing (1)
  • Autophagy & Cell Death (16)
  • Cell Cycle (31)
  • Chemical Biology (1)
  • DNA Replication, Repair & Recombination (10)
  • Evolution (8)
  • Genetics, Gene Therapy & Genetic Disease (4)
  • Membrane & Intracellular Transport (17)
  • Metabolism (76)
  • Microbiology, Virology & Host Pathogen Interaction (71)
  • Neuroscience (15)
  • Pharmacology & Drug Discovery (8)
  • Protein Biosynthesis & Quality Control (29)
  • RNA Biology (41)
  • Structural Biology (14)
  • Cancer (20)
  • Cell Adhesion, Polarity & Cytoskeleton (11)
  • Chromatin, Epigenetics, Genomics & Functional Genomics (201)
  • Computational Biology (221)
  • Development & Differentiation (45)
  • Genome-Scale & Integrative Biology (110)
  • Immunology (18)
  • Methods & Resources (51)
  • Molecular Biology of Disease (51)
  • Network Biology (180)
  • Plant Biology (36)
  • Post-translational Modifications, Proteolysis & Proteomics (101)
  • Quantitative Biology & Dynamical Systems (75)
  • Signal Transduction (105)
  • Stem Cells (6)
  • Synthetic Biology & Biotechnology (64)
  • Systems Medicine (8)
  • Transcription (38)

Journal

  • Home
  • Latest Content
  • Archive
  • Bibliometrics
  • E-Mail Editorial Office

Authors & References

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1744-4292

Copyright© 2018 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.